8GAV

Structure of human NDS.3 Fab in complex with influenza virus neuraminidase from A/Darwin/09/2021 (H3N2)

8GAV の概要

• エントリーDOI: 10.2210/pdb8gav/pdb
• EMDBエントリー: 29907 29908 29909
• 分子名称: Neuraminidase, Fab NDS.3, heavy chain, Fab NDS.3, light chain, ... (4 entities in total)
• 機能のキーワード: neuraminidase, antibody, influenza, viral protein-immune system complex, viral protein/immune system
• 由来する生物種: Influenza A virus; 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 99708.35

構造登録者

Tsybovsky, Y.,Lederhofer, J.,Kwong, P.D.,Kanekiyo, M. (登録日: 2023-02-23, 公開日: 2024-02-28, 最終更新日: 2025-05-28)

主引用文献

Lederhofer, J.,Tsybovsky, Y.,Nguyen, L.,Raab, J.E.,Creanga, A.,Stephens, T.,Gillespie, R.A.,Syeda, H.Z.,Fisher, B.E.,Skertic, M.,Yap, C.,Schaub, A.J.,Rawi, R.,Kwong, P.D.,Graham, B.S.,McDermott, A.B.,Andrews, S.F.,King, N.P.,Kanekiyo, M.
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.
Immunity, 57:574-586.e7, 2024

PubMed Abstract: Continuously evolving influenza viruses cause seasonal epidemics and pose global pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target, our understanding of the NA antigenic landscape still remains incomplete. Here, we describe NA-specific human antibodies that target the underside of the NA globular head domain, inhibit viral propagation of a wide range of human H3N2, swine-origin variant H3N2, and H2N2 viruses, and confer both pre- and post-exposure protection against lethal H3N2 infection in mice. Cryo-EM structures of two such antibodies in complex with NA reveal non-overlapping epitopes covering the underside of the NA head. These sites are highly conserved among N2 NAs yet inaccessible unless the NA head tilts or dissociates. Our findings help guide the development of effective countermeasures against ever-changing influenza viruses by identifying hidden conserved sites of vulnerability on the NA underside.

PubMed: 38430907
DOI: 10.1016/j.immuni.2024.02.003

実験手法

ELECTRON MICROSCOPY (2.7 Å)